CLINICAL_TRIALS
trial_result
· 2014-05-02
Clinical Trial Update: Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes [Phase 3]
Summary
A Phase 3 study evaluated the safety and efficacy of dapagliflozin as monotherapy in adults with type 2 diabetes, with results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AstraZeneca | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2014-05-02